在COPD中解码LncRNA:揭示预后和诊断能力及其在肺癌进展中的驱动作用
Osama Sweef1,2, Reda Mahfouz3,4, Tülin Taşcıoğlu5
1Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center, School of Medicine, Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, OH 44109, USA.
International journal of molecular sciences
|August 29, 2024
概括
长非编码RNAs (lncRNAs) 是慢性阻塞性肺病 (COPD) 和肺癌的关键参与者. 它们的失调为这些具有挑战性的呼吸道疾病提供了新的诊断和治疗策略.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性阻塞性肺病 (COPD) 和肺癌是全球主要的健康问题,具有复杂的潜在机制.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在各种生物过程和疾病中的调节作用.
研究的目的:
- 审查lncRNAs在COPD和肺癌的发病过程中的多方面的作用.
- 探索 lncRNAs 在这些呼吸系统疾病中的诊断,预后和治疗影响.
主要方法:
- 综合多种研究视角的综合文献综述.
- 在COPD和肺癌病原发生过程中对lncRNA失调的分析.
- 检查肺癌中 lncRNA介导的免疫反应.
主要成果:
- 特定的lncRNAs (NEAT1,TUG1,MALAT1,HOTAIR,GAS5) 与COPD的发病和进展有关.
- LncRNAs调节肺癌的进展,免疫反应和化疗抵抗.
- 失调的 lncRNAs 作为两种疾病的潜在诊断和预后生物标志物.
结论:
- 对于开发COPD和肺癌的新型诊断和治疗策略,LncRNAs具有显著的潜力.
- 对基于lncRNA的干预措施的进一步研究可能会导致个性化治疗和改善临床结果.
关键词:
慢性阻塞性肺病 (COPD) 是一种慢性阻塞性肺病.诊断生物标志物 生物标志物这是一种炎症炎症炎症炎症.长非编码RNAs (lncRNAs) 是一种非编码RNA.肺癌是一种肺癌.分子病变发生的分子病变发生.更多相关视频
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.6K
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.1K
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
COPD: Pathogenesis and Clinical Features
244
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
244
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
